|
- 2018
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?DOI: 10.1186/s13613-018-0431-5 Keywords: Astragaloside IV, Antioxidant therapy, Rhabdomyolysis, Crush syndrome, Ischemia–reperfusion injury Abstract: PMH and HDS designed the paper. PMH, DDB, and HDS participated in drafting and reviewing the paper. All authors read and approved the final manuscript
|